A review on the design and reporting of studies on drug-gene interaction

Journal of Clinical Epidemiology

Volumn 58, Issue 7, 2005, Pages 651-654

  Smits, Kim M ^a   Schouten, Jan S ^a   Smits, Luc J ^a   Stelma, Foekje F ^a   Nelemans, Patty ^a   Prins, Martin H ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Drug gene interactions; Effect modification; Methodology; Pharmacogenetics; Study design and reporting; Study quality

Indexed keywords

BIOMATERIAL;

COMPARATIVE STUDY; DRUG INTERACTION; GENE EXPRESSION; GENE INTERACTION; GENOTYPE; HUMAN; METHODOLOGY; PHARMACOGENETICS; PRIORITY JOURNAL; PROGNOSIS; QUALITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

EID: 20444362761     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2005.01.001     Document Type: Article

References (20)

1. D. Moher CONSORT: an evolving tool to help improve the quality of reports of randomized controlled trials. Consolidated Standards of Reporting Trials JAMA 279 1998 1489 1491
2. S.T. Bogardus Jr., J. Concato, and A.R. Feinstein Clinical epidemiological quality in molecular genetic research: the need for methodological standards JAMA 281 1999 1919 1926
3. 2-adrenergic receptor on the response to regular use of albuterol in asthma Am J Respir Crit Care Med 162 2000 75 80
4. 2-adrenoceptor on the development of tolerance to beta-agonist J Asthma 37 2000 691 700
5. 2 adrenoceptor polymorphism Thorax 55 2000 762 767
6. 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics Lancet 350 1997 995 999
7. 2- Adrenergic receptor polymorphisms affect airway responsiveness to salbutamol in asthmatics J Asthma 36 1999 583 590
8. 2-adrenergic receptor on albuterol bronchodilator pharmacodynamics Clin Pharmacol Ther 65 1999 519 525
9. W. Steimer, and J.M. Potter Pharmacogenetic screening and therapeutic drugs Clin Chim Acta 315 2002 137 155
10. A.H. Maitland-van der Zee, A. de Boer, and H.G. Leufkens The interface between pharmacoepidemiology and pharmacogenetics Eur J Pharmacol 410 2000 121 130
11. K.J. Rothman, and S. Greenland Modern epidemiology 2nd ed. 1998 Lippincott-Raven Philadelphia
12. J. Koopman Interaction between discrete causes Am J Epidemiol 113 1981 716 724
13. D.L. Sackett, S.E. Straus, W.S. Richardson, W. Rosenberg, and R.B. Haynes Evidence-based medicine: how to practice and teach EBM 2nd ed. 2000 Churchill Livingstone Edinburgh
14. R.J. Cook, and D.L. Sackett The number needed to treat: a clinically useful measure of treatment effect BMJ 310 1995 452 454 [Erratum in: BMJ 1995;310:1056]
15. R.H. Fletcher, S.W. Fletcher, and E.H. Wagner Clinical epidemiology: the essentials 3rd ed. 1996 Williams & Wilkins Baltimore
16. 2-adrenoceptor and response to albuterol in children with and without a history of wheezing J Clin Invest 100 1997 3184 3188
17. D.K. Kim, S.W. Lim, S. Lee, S.E. Sohn, S. Kim, C.G. Hahn, and B.J. Carroll Serotonin transporter gene polymorphism and antidepressant response Neuroreport 11 2000 215 219
18. S. Greenland Tests for interaction in epidemiologic studies: a review and a study of power Stat Med 2 1983 243 251
19. A.P. Verhagen, H.C. de Vet, R.A. de Bie, A.G. Kessels, M. Boers, L.M. Bouter, and P.G. Knipschild The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus J Clin Epidemiol 51 1998 1235 1241
20. D. Moher, A.R. Jadad, G. Nichol, M. Penman, P. Tugwell, and S. Walsh Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists Control Clin Trials 16 1995 62 73